FOLFOXIRI + Bevacizumab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for FOLFOXIRI + Bevacizumab, covering 2019-04-11 to 2023-10-12. Get the full timeline:
Most recent: Clinical Trial Update: FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients [Phase 2]